Market›Health Care›Pharmaceuticals›Pharmaceuticals
CNBX PHARMACEUTICALS

CNBX

$0.00Apr 28, 2021 – Apr 27, 2026
Health CarePharmaceuticals$0M
MVM
+$0.0M

Every news event mapped to its market reaction — 30 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2022-12-29-29.2%legalSEC EDGARCNBX 8-K: 5.02 (SEC Filing)
2026-04-14-27.0%newsStock TitanCNBX (OTCQB: CNBX) widens loss as cash dwindles and share count surges - Stock Titan
2026-04-14-27.0%earningsmarketscreener.comCNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2026 - marketscreener.com
2025-01-30-22.5%legalSEC EDGARCNBX 8-K: 1.01 and (SEC Filing)
2022-10-13+19.1%newsSeeking AlphaCNBX files patent application for cancer treatment with cannabinoids in US and Israel
2023-02-08-15.7%legalSEC EDGARCNBX 8-K: 5.02 (SEC Filing)
2022-05-05+13.8%newsSeeking AlphaCNBX pharma granted patent in Hong Kong for cancer therapy
2022-03-28-10.8%legalSEC EDGARCNBX 8-K: 5.03, 8.01 (SEC Filing)
2021-05-06+10.1%newsSeeking AlphaCannabics gets "notice of allowance" from the Mexican Patent and Trademark Office
2021-06-17+7.6%expansionSeeking AlphaCannabics to launch new drug development programs
2021-10-14+5.7%executiveNasdaqCEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference - Nasdaq
2021-06-28+5.3%newsSeeking AlphaCannabics posts interim results from RCC-33 colorectal cancer mice study
2022-02-17+4.2%legalSEC EDGARCNBX 8-K: 1.01 and (SEC Filing)
2021-05-11-3.7%newsSeeking AlphaCannabics files a PCT patent application for proprietary cancer treatment formulations
2021-05-25+2.8%newsSeeking AlphaCannabics gets European Patent for personalized medicine drug discovery technology
2026-03-30-2.6%newsTipRanksDE:8C80 Stock Latest News - TipRanks
2021-09-13-2.1%legalSEC EDGARCNBX 8-K: 5.02 and (SEC Filing)
2021-09-14-1.7%newsThe Motley FoolAffymax - AFFY - Stock Price & News - The Motley Fool
2021-07-06-1.3%legalSEC EDGARCNBX 8-K: 5.02 and (SEC Filing)
2026-03-17+1.1%legalSEC EDGARCNBX 8-K: 1.01 and (SEC Filing)
2026-03-17+1.1%earningsMinichartCNBX Pharmaceuticals Executes $45,000 Non-Convertible Promissory Note with 3i L.P. – SEC 8-K Filing March 2026 7 - Minichart
2022-03-16+1.1%legalSEC EDGARCNBX 8-K: 1.01, 2.03 (SEC Filing)
2022-07-25+1.1%legalSEC EDGARCNBX 8-K: 5.02 (SEC Filing)
2021-11-19-0.6%legalSEC EDGARCNBX 8-K: 5.02 (SEC Filing)
2026-04-22-0.6%newsMeykaCNBX Stock Plunges 25% on Apr 22 as Biotech Faces Headwinds - Meyka
2025-07-14+0.2%newsStockInvest.usCNBX Pharmaceuticals Faces Financial Struggles Amid Cuts and Hope for Clinical Trials - StockInvest.us
2021-10-18-0.2%newsSeeking AlphaCannabics files new provisional patent applications
2021-07-19-0.1%legalSEC EDGARCNBX 8-K: 5.02 and (SEC Filing)
2021-07-07+0.1%newsSeeking AlphaCannabics names Inbar Maymon-Pomeranchik as independent board director
2021-04-28—legalSEC EDGARCNBX 8-K: 1.01, 5.04 (SEC Filing)
tickerdossier.comtickerdossier.substack.com